Search for: "NATIONAL LEGISLATIVE ASSOCIATION ON PRESCRIPTION DRUG PRICES" Results 1 - 20 of 104
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
2 Jan 2024, 12:56 pm by Kevin LaCroix
Thus, by my tally there were 25 securities class action lawsuits filed against companies in the 283 SIC Code Industry Group (Drugs), including 17 in the 2834 SIC Code category (Pharmaceutical Preparations). [read post]
29 Nov 2023, 5:04 pm by Robert Hill and Matthew Loughran
Among its other provisions, the bill, for which final legislative text has not yet been released, would, for the first time, mandate minimum prices that Medicare Part D plans, and the pharmacy benefit managers (PBMs) with which they contract, must pay to certain types of pharmacies as reimbursement for the drugs they dispense to Part D plan enrollees. [read post]
20 Sep 2023, 2:10 am by Christine Cooper, aequum LLC
  As many mental health conditions are treated with prescription drugs, another solution might include effectively designed acquisition cost-based pharmacy pricing. [read post]
20 Sep 2023, 2:10 am by Christine Cooper, aequum LLC
  As many mental health conditions are treated with prescription drugs, another solution might include effectively designed acquisition cost-based pharmacy pricing. [read post]
2 Jun 2023, 2:50 am by Kurt R. Karst
  Nevertheless, riding on the wave of drug price transparency legislation in several states and similar legislative proposals in Congress, CMS is proposing to expand the MDRP into the realm of drug price transparency reporting. [read post]
22 May 2023, 7:46 am by Constance A. Wilkinson
For example, Representative Buddy Carter (R-GA) recently introduced legislation, Drug Price Transparency in Medicaid Act (H.R. 1613), to impose a federal ban on spread pricing in Medicaid managed care and require pharmacies to be reimbursed a minimum of a drug’s national average drug acquisition cost (“NADAC”).[15] CMS establishes NADAC—a federal pricing benchmark utilized by CMS for Medicaid… [read post]
6 Mar 2023, 5:16 am by Justin Sherman
These regulations established national privacy and security standards related to electronic health information. [read post]
28 Nov 2022, 1:42 pm by Cynthia Marcotte Stamer
  See, e.g., Fact Sheet: President Biden To Announce Strategy To Address Our National Mental Health Crisis, As Part Of Unity Agenda In His First State Of The Union; President Biden Releases National Drug Control Strategy to Save Lives, Expand Treatment, and Disrupt Trafficking; Actions Taken by the Biden-⁠Harris Administration to Address Addiction and the Overdose Epidemic; Colorado Springs LGBT Nightclub Shooting Leaves Five Dead and 25… [read post]
12 Oct 2022, 9:05 pm by Trevor Kirby
Senators Bob Casey (D-Pa.) and Susan Collins (R-Maine) have introduced bipartisan legislation to increase drug price transparency. [read post]
16 Aug 2022, 6:08 am by Philip Mousavizadeh
The sweeping legislation seeks to lower prescription drug prices, boost the renewable energy sector, and impose new taxes on large corporations. [read post]
29 Jul 2022, 1:39 pm by Kevin Kaufman
Indeed, the Congressional Budget Office (CBO) expects federal spending to reach 30 percent of GDP by 2052, a level most associated with European nations. [read post]
15 May 2022, 9:11 pm by The Regulatory Review Staff
November 12, 2020 | FDA and the Importation of Prescription Drugs | Scholars evaluate a recent FDA rule that creates an importation program for Canadian prescription drugs. [read post]
30 Dec 2021, 9:03 pm by Katelynn Catalano
” The Supreme Court unanimously held that the National Collegiate Athletic Association (NCAA) cannot ban schools from providing their athletes with education-related benefits, such as graduate scholarships or tutoring. [read post]
17 Nov 2021, 2:44 pm by Cynthia Marcotte Stamer
The Departments say additional information on prescription drug rebates, fees, and other remunerations paid by drug manufacturers to plans, issuers, and pharmacy benefit managers—including the top 25 drugs generating the highest rebate amounts—will help the Departments understand and report on prescription drug costs, and how they fluctuate over time. [read post]
12 Nov 2021, 3:00 am by Jim Sedor
Pharmaceutical Industry Likely to Shatter Its Lobbying Record as It Works to Shape Democrats’ Spending Bill MSN – Yeganeh Torbati and Jonathan O’Connell (Washington Post) | Published: 11/5/2021 Ads targeting lawmakers who supported allowing Medicare to negotiate prescription drug prices were one strand of a massive, months-long advertising, lobbying and political donation campaign undertaken by the pharmaceutical industry and its allies, perhaps… [read post]
30 Sep 2021, 4:50 pm by Cynthia Marcotte Stamer
In addition to the Act’s requirements implemented by these three rule packages, health plans and health providers also need to begin preparing to comply with new rules regarding prescription drug coverages and various other requirements of the Act, as well as a plethora of regulatory and market changes impacting health plans and their administration that have emerged over the past year. [read post]
4 Jan 2021, 2:02 pm by Cynthia Marcotte Stamer
  As the effects of the COVID-19 pandemic began to be felt in the United States, the defendants used the COVID-19 pandemic as an opportunity to capitalize on a national emergency for their own financial gain by using the COVID-19 “emergency override” billing codes to submit fraudulent claims for Targretin Gel 1%, which has an average wholesale price of approximately $34,000 for each 60 gram tube. [read post]
March 13 – Declaration of National Emergency The President declared a national state of emergency under the Stafford Act for all U.S. states, territories and possessions. [read post]
13 Dec 2020, 7:09 pm by Ronald Mann
Pharmaceutical Care Management Association firmly rejected an attack on state statutes that protect pharmacies from the prescription-reimbursement intermediaries that health-insurance providers use to administer their prescription-drug programs. [read post]